共 50 条
- [3] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu [J]. Nuclear Medicine and Molecular Imaging, 2022, 56 : 313 - 322
- [4] Requirements on specific activity (SA) of 177Lu to radiolabel DOTATATE for PRRT: studies on labeling 0.2 mg DOTATATE with 7.4 GBq 177Lu at several SA of 177Lu [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56
- [7] Eruption of Metastatic Paraganglioma After Successful Therapy with 177Lu/90Y-DOTATOC and 177Lu-DOTATATE [J]. Nuclear Medicine and Molecular Imaging, 2019, 53 : 223 - 230
- [8] Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2566 - 2572
- [10] Extravasation After [177Lu]Lu-HA-DOTATATE Therapy [J]. CLINICAL NUCLEAR MEDICINE, 2024, 49 (05) : 454 - 456